Regulation of hepatic apolipoprotein-B-containing lipoprotein secretion

Current Opinion in Lipidology

Volumn 7, Issue 3, 1996, Pages 132-138

  Pease, Richard J ^a   Leiper, James M ^a  

^a UNIVERSITY COLLEGE LONDON   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

APOLIPOPROTEIN B; CARRIER PROTEIN; CHOLESTEROL; CHOLESTEROL ESTER; TRIACYLGLYCEROL; VERY LOW DENSITY LIPOPROTEIN;

HUMAN; LIPID LIVER LEVEL; LIPID METABOLISM; LIPID TRANSPORT; LIPOLYSIS; LIPOPROTEIN SECRETION; NONHUMAN; PRIORITY JOURNAL; PROTEIN DEGRADATION; REVIEW;

EID: 0030054587     PISSN: 09579672     EISSN: None     Source Type: Journal    
DOI: 10.1097/00041433-199606000-00004     Document Type: Review

References (51)

1. Sharp D, Blinderman L, Combs KA, Kienzle B, Ricci B, Wager-Smith K, Gil CM, Turk CW, Bouma M-E, Rader DJ et al.: Cloning and gene defects in microsomal triglyceride transfer protein associated with abetalipoproteinaemia. Nature 1993, 365:65-69.
2. Wetterau JR, Aggerbeck LP, Laplaud M, McLean LR: Structural properties of the microsomal triglyceride transfer protein complex. Biochemistry 1991, 30:4406-4412.
3. Atzel A, Wetterau JR: Identification of two classes of lipid molecule binding site on the microsomal triglyceride transfer protein. Biochemistry 1994, 33:15382-15388.
4. Jamil H, Dickson JK, Chu CH, Lao MW, Rinehart JK, Biller SA, Gregg RE, Wetterau JR: Microsomal triglyceride transport protein. Specificity of lipid binding and transport J Biol Chem 1995, 270:6549-6554. In-vitro transfer reactions show that transfer is a general function of the hydrophobicity of the lipids with no apparent discrimination of the hydrophilic headgroups on phospholipids. MTP specificity cannot explain the apparent differences in lipid composition between VLDL and the ER membrane.
5. Ricci B, Sharp D, O'Rourke E, Kienzle B, Blinderman L, Gordon D, Robinson G, Gregg RE, Rader DJ, Wetterau JR: A 30 amino acid truncation of the microsomal triglyceride transfer protein large subunit disrupts its interaction with protein disulphide isomerase and causes abetalipoproteinemia. J Biol Chem 1995, 270:14281-14285. A carboxyl-terminal deletion of 30 amino acids from the 98 kDa subunit prevents interaction with protein disulphide isomerase when expressed in baculovirus-infected insect cells This may reflect a specific interaction, although a general effect on protein folding caused by loss of cysteines (866 and 878) was not excluded.
6. Gordon DA, Jamil H, Sharp D, Mullaney D, Yao Z, Gregg RE, Wetterau J: Secretion of apolipoprotein B containing lipoproteins from HeLa cells is dependent on expression of microsomal triglyceride transfer protein and is regulated by lipid availability. Proc Natl Acad USA 1994, 91:7628-7632. Transient transfection of apoB53 into HeLa cells stably transfected with MTP resulted in secretion of lipoproteins of HDL density.
7. Leiper JM, Bayliss JD, Pease RJ, Brett DJ, Scott J, Shoulders CC: Microsomal triglyceride transfer protein, the abetalipoproteinemia gene product, mediates the secretion of apolipoprotein B containing lipoproteins from heterologous cells. J Biol Chem 1994, 269:21951-21954. Transient cotranslection of MTP with apoB41 in COS cells resulted in secretion of lipoproteins d= 1.25-1.3 g cm .
8. 3) even though MTP is undetectable.
9. Lin MC, Arbeeny C, Bergquist K, Kienzle B, Gordon DA, Wetterau JR: Cloning and regulation of hamster microsomal triglyceride transfer protein. J Biol Chem 1994, 269:29138-29145. A solution hybridization assay was used to quantitate MTP mRNA levels in Syrian hamsters. Fat feeding caused an increase of mRNA in liver (55%) and intestine (126%), sucrose feeding caused a specific increase in liver (55%), while fasting had no effect.
10. Bennett AJ, Billet MA, Salter AM, White DA: Regulation of hamster hepatic microsomal triglyceride transfer protein mRNA levels by dietary fats. Biochem Biophys Res Comm 1995, 212:473-478. Dietary fatty acids, particularly saturated fatty acids, increase the hepatic MTP message up to 60%, measured by solution hybridization.
11. Hagan DL, Kienzle B, Jamil H, Hariharan N: Transcriptional regulation of human and hamster microsomal triglyceride transfer protein genes. Cell-type specific expression and response to metabolic regulators. J Biol Chem 1994, 269(46):28737-28744.
12. Lin MCM, Gordon D, Wetterau JR: Microsomal triglyceride transfer protein regulation in Hep G2 cells. Insulin negatively regulates MTP gene expression. J Lipid Res 1995, 36:1073-1081. Acute decreases in MTP large subunit RNA were detected within several hours of incubation with insulin. Much greater insulin sensitivity was apparent than had previously been reported in [11].
13. Duerden JM, Gibbons GF: Restoration of normal rates of very-low-density lipoprotein triacyglycerol and apoprotein B secretion in hepatocyte cultures from diabetic rats. Biochem J 1993, 294:167-171.
14. Yang LY, Kuksis A, Steiner G Comparison of the effect of hyper-insulinemia on acyl-coA acyl transferase activity in the liver and intestine of the rat. Atherosclerosis 1994, 107:25-34.
15. Brett DJ, Pease RJ, Scott J, Gibbons GF: Microsomal triglyceride transfer activity remains unchanged in rat livers under conditions of altered very-low-density lipoprotein secretion. Biochem J 1995, 310:11-14. In streptozotocin-induced diabetes and during the suckling period, rats markedly decrease VLDL secretion, but this is not accompanied by a decrease in either MTP enzyme activity or immunoreactive MTP protein.
16. Gibbons GF, Wiggins D, The enzymology of hepatic very-low-density lipoprotein secretion. Biochem Soc Trans 1995, 23:495-500.
17. Wiggins D, Gibbons F: The lipolysis reesterification cycle. Its role in the secretion of very low density lipoproteins and its response to hormones and sulphonylureas. Biochem J 1992, 284:457-462.
18. Yang LY, Kuksis A, Myher JJ, Steiner G: Origin of triacylglycerol moiety of plasma very low density lipoproteins in the rat: structural studies. J Lipid Res 1995, 36:125-136. The chemical structure of rat hepatic intracellular TAG was compared with that of plasma VLDL-TAG by gas chromatography-mass spectrometry. The fatty acyl chains in the 1.2 positions were conserved while position 3 was exchanged, suggesting lipolysis to diacylglycerol followed by re-esterification.
19. 3H]oleic acid allows lipolysis of TAG to FA plus glycerol to be measured since unlabelled newly synthesized glycerol competes for re-estenfication. TAG turnover in HepG2 cells is reduced 10-fold with respect to primary hepatocytes. although TAG synthesis is unaffected.
20. Pullinger CR, North JD, Teng BB, Rifici VA, Ronhild-de Brito AE, Scott J: The apolipoprotein gene is constitutively expressed in HepG2 cells: regulation of secretion by oleic acid albumin and insulin. J Lipid Res 1989, 30:1065-1077.
21. Lin Y, Smit MJ, Havinga R, Verkade HJ, Vonk RJ, Kuipers F: Differential effects of eicosapentanoic acid on glycerolipid and apolipoprotein B metabolism in primary human hepatocytes compared to HepG2 cells and primary rat hepatocytes. Biochim Biophys Acta 1995, 1256:88-96.
22. Kurokawa M, Hirano T, Furukawa S, Nagano S, Adachi M: Similar to oleic acid, eicosapentanoic acid stimulates apolipoprotein B secretion by inhibiting its intracellular degradation in Hep G2 cells. Atherosclerosis 1995, 112:59-68.
23. 100 containing lipoproteins. Prog Lipid Res 1991, 30:205-218.
24. 100-HDL that was present appeared to be derived from failed cotranslational assembly rather than being a precursor.
25. 48-VLDL. Maturation occurs within a time of 15 min in the rough ER .
26. Rusinol AE, Cui Z, Chen MH, Vance JE: A unique mitochondrial associated membrane fraction from rat liver has a high capacity for lipid synthesis and contains pre-Golgi secretory proteins including nascent lipoproteins. J Biol Chem 1994, 269:27494-27502. MAM is shown by immunocytochemistry with an antibody against phosphatidyl ethanolamine N-methyl transferase to be distinct from the bulk of the smooth ER or rough ER. Isolated MAM from rat liver contains MTP and nascent lipoprotein articles that are similar in size to those in the rough ER and Golgi.
27. Vance JE: Phospholipid synthesis in a membrane fraction associated with mitochondria. J Biol Chem 1990, 265:7248-7256.
28. Merrill AH, Lingrell S, Wang E, Nikova-Karakashian M, Vales TR, Vance DE: Sphingolipid biosynthesis de novo by rat hepatocytes in culture. J Biol Chem 1995, 270:13834-13841.
29. Huff MW, Telford DE, Barrett PH, Bilheimer JT, Gillies PJ: Inhibition of hepatic ACAT decreases apoB secretion in miniature pigs fed a cholesterol free diet. Artenoscler Thromb 1994, 14:1498-1508. Administration of the ACAT inhibitor DuP 128 to pigs led to a 68% decrease in ACAT activity, a 65% decrease in VLDL apoB secretion and a 40% decrease in VLDL-TAG. Intracellular TAG or CE levels were unchanged
30. Carr TP, Hamilton RL, Rudel LL: ACAT inihibitors decrease secretion of cholesteryl esters and apolipoprotein B by perfused livers of African green monkeys. J Lipid Res 1995, 36:25-36. Three separate ACAT inhibitors were evaluated, all of which can decrease apoB and CE secretion. One inhibitor, CI-976, showed greater specificity than the others and decreased apoB and CE without changing TAG secretion.
31. Nagayoshi A, Matsuki N, Saito H, Tsukamoto K, Wakashima M, Kinoshita M, Yamanaka M, Teramoto T: Deficiency of acyl Co A acyl transferase in Suncus liver, J Biochem Tokyo 1994, 115:858-861.
32. 13C]leucine infusion protocols.
33. 100 in heterozygous familial hypercholesterolemia: a stable isotope study. Atherosclerosis 1995, 113:79-89. An increase in the absolute secretion rate of apoB again correlates with increased plasma mevalonate A parallel increase in VLDL-TAG secretion was not seen
34. Cummings MH, Watts GF: Increased hepatic secretion of very low density lipoprotein apoB100 in cholesterol ester storage disease. Clin Chem 1995, 41:111-114.
35. Hoang VQ, Pearce NJ, Suckling KE, Botham KM: Evaluation of cultured hamster hepatocytes as an experimental model for the study of very low density lipoprotein secretion. Biochim Biophys Acta 1995, 1254:37-44.
36. Wu X, Sakata N, Lui E, Ginsberg HN: Evidence for a lack of regulation of the assembly and secretion of apolipoprotein B containing lipoprotein from HepG2 cells by cholesterol ester. J Biol Chem 1994, 269:12375-12382.
37. Cianflone K, Vu H, Zhang Z, Sniderman AD Effects of albumin on lipid synthesis, apoB-100 secretion and LDL catabolism in HepG2 cells. Atherosclerosis 1994, 107:125-135
38. Davis RA, Thrift RN, Wu CC, Howell KE: Apolipoprotein B is both integrated into and translocated across the endoplasmic reticulum membrane. Evidence for two functionally distinct pools. J Biol Chem 1990, 265:10005-10011.
39. Du EZ, Kurth J, Wang SL, Humiston P, Davis RA Proteolysis coupled secretion of the N terminus of apolipoprotein B. Characterization of a transient translocation arrested intermediate. J Biol Chem 1994, 269:24169-24176.
40. Rusinol AE, Vance JE: Inhibition of secretion of truncated apolipoproteins B by monomethylethanolamine is independent of the length of the apolipoprotein. J Biol Chem 1995, 270:13318-13325.
41. Zhou M, Wu X, Huang L-S, Ginsberg HN: Apoprotein B100 an inefficiently translocated secretory protein is bound to the cytosolic chaperone heat shock protein 70. J Biol Chem 1995, 270:25220-25224.
42. 1 , is measured in dually labelled rat hepatocytes. This ratio is two-fold higher in the intracellular pool, which is consistent with complete intracellular mannosylation followed by trimming back before secretion
43. Sturley SL, Talmud PJ, Brasseur R, Culbertson MR, Humphries SE, Attie AD: Human apolipoprotein signal sequence variants confer a secretion-defective phenotype when expressed in yeast J Biol Chem 1994, 269:21670-21675.
44. Chuck SL, Lingappa VR Pause transfer a topogenic sequence in apolipoprotein B mediates stopping and restarting of translocation. Cell 1992, 68:9-21.
45. Nakahara DH, Lingappa VR, Chuck SL: Translocational pausing is a common step in the biogenesis of unconventional integral membrane and secretory proteins. J Biol Chem 1994, 269:7617-7622.
46. Hay B, Prusiner SB, Lingappa VR: Evidence for a secretory form of the prion protein. Biochemistry 1987, 26:8110-8115.
47. De Fea KA, Nakahara DH, Calayag MC, Yost CS, Mirels LF, Prusiner SB, Lingappa VR: Determinants of carboxyl terminal domain translocation during prion biogenesis. J Biol Chem 1994, 269:16810-16820. While the transmembrane form of prion protein has not been detected in normal cells, a transient 'metastable' transmembrane topology can be detected when in vitro transcribed RNA is injected into Xenopus oocytes
48. Sallach SM, Adeli K Intracellular degradation of apolipoprotein B generates an N terminal 70kDa fragment in the endoplasmic reticulum. Biochim Biophys Acta 1995, 1265:29-32.
49. Adeli K, Mohammadi A, Macri J: Regulation of apolipoprotein B biogenesis in human hepatocytes: posttranslational control mechanisms which determine the hepatic production of apolipoprotein B containing lipoproteins. Clinical Biochemistry 1995, 28:123-130.
50. Pease RJ, Leiper JM, Harrison GB, Scott J: Studies on the translocation of the amino terminus of apolipoprotein B into the endoplasmic reticulum. J Biol Chem 1995, 270:7261-7271. Conditions that cause apoB to adopt a transmembrane configuration by in-vitro translation also result in the cytosolic protein cyclin becoming transmembrane. It was suggested that ribosome pausing rather than specific protein signals determines this topology, i.e the results may simply reflect an artefact of the lysate conditions.
51. Pease RJ, Milne RW, Jessup WK, Law A, Provost P, Fruchart JC, Dean RT, Marcel YL, Scott J: Use of bacterial expression cloning to localize the epitopes for a series of monoclonal antibodies against apolipoprotein B100. J Biol Chem 1990, 265:553-568.